📰 Microsatellite Stable News
Microsatellite Stable News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Microsatellite Stable. Real-time updates on events, politics, business and more.
January 22, 2024
22.01.2024 - Agenus Inc. (Nasdaq: AGEN), a leader in developing immunological cancer treatments, today announced results from the NEST-1 study, an investigator-sponsored trial (IST) evaluating the combination of botensilimab and balstilimab (BOT/BAL) in the ... Seite 1
September 13, 2023
The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.
August 21, 2023
Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.
August 2, 2023
– Achieved Second Quarter 2023 Total Revenue of $37.6 Million and U.S. XPOVIO® (selinexor) Net Product Revenue of $28.5 Million – – Maintains Full Year 2023...
July 5, 2023
The combination of botensilimab and balstilimab elicited durable responses and provided overall survival benefits in patients with microsatellite stable metastatic colorectal cancer that is resistant to chemotherapy and/or immunotherapy.
July 21, 2022
HTL0039732 is a novel EP4 antagonist with potential to treat a wide range of cancers in combination with other immunotherapies...